All lobbying filings

AVENUE SOLUTIONS

Lobbying for SIEMENS MEDICAL SOLUTIONS USA, INC. · Healthcare diagnostics

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $70,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 4

HR 6197
Health Tech Investment Act
S 1399
Health Tech Investment Act
HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Lobbying activity 3

Health Issues

Issues related to healthcare data privacy; Issues related to Artificial Intelligence within the healthcare sector; H.R. 6197/S. 1399, Health Tech Investment Act

Medicare/Medicaid

Monitor issues related to site neutral payments; Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Trade (domestic/foreign)

Issues related to medical supply chains and procurement

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.